An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

被引:144
作者
Chakraverty, Ronjon
Cote, Daniel
Buchli, Jennifer
Cotter, Pete
Hsu, Richard
Zhao, Guiling
Sachs, Teviah
Pitsillides, Costas M.
Bronson, Roderick
Means, Terry
Lin, Charles
Sykes, Megan [1 ]
机构
[1] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02129 USA
[3] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02129 USA
关键词
D O I
10.1084/jem.20060376
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transfer of T cells to freshly irradiated allogeneic recipients leads to their rapid recruitment to nonlymphoid tissues, where they induce graft-versus-host disease (GVHD). In contrast, when donor T cells are transferred to established mixed chimeras (MCs), GVHD is not induced despite a robust graft-versus-host (GVH) reaction that eliminates normal and malignant host hematopoietic cells. We demonstrate here that donor GVH-reactive T cells transferred to MCs or freshly irradiated mice undergo similar expansion and activation, with similar up-regulation of homing molecules required for entry to nonlymphoid tissues. Using dynamic two-photon in vivo microscopy, we show that these activated T cells do not enter GVHD target tissues in established MCs, contrary to the dogma that activated T cells inevitably traffic to nonlymphoid tissues. Instead, we show that the presence of inflammation within a nonlymphoid tissue is a prerequisite for the trafficking of activated T cells to that site. Our studies help to explain the paradox whereby GVH-reactive T cells can mediate graft-versus-leukemia responses without inducing GVHD in established MCs.
引用
收藏
页码:2021 / 2031
页数:11
相关论文
共 59 条
[51]   IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation [J].
Teshima, T ;
Hill, GR ;
Pan, LY ;
Brinson, YS ;
van den Brink, MRM ;
Cooke, KR ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :317-325
[52]   Acute graft-versus-host disease does not require alloantigen expression on host epithelium [J].
Teshima, T ;
Ordemann, R ;
Reddy, P ;
Gagin, S ;
Liu, C ;
Cooke, KR ;
Ferrara, JLM .
NATURE MEDICINE, 2002, 8 (06) :575-581
[53]  
TOMITA Y, 1994, J IMMUNOL, V153, P1087
[54]   Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction [J].
Vezys, V ;
Olson, S ;
Lefrançois, L .
IMMUNITY, 2000, 12 (05) :505-514
[55]   Cutting edge:: Inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen [J].
Vezys, V ;
Lefrançois, L .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6677-6680
[56]   Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease [J].
Waldner, H ;
Collins, M ;
Kuchroo, VK .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) :990-997
[57]   Homeostatic proliferation is a barrier to transplantation tolerance [J].
Wu, ZH ;
Bensinger, SJ ;
Zhang, JD ;
Chen, CQ ;
Yuan, XL ;
Huang, XL ;
Markmann, JF ;
Kassaee, A ;
Rosengard, BR ;
Hancock, WW ;
Sayegh, MH ;
Turka, LA .
NATURE MEDICINE, 2004, 10 (01) :87-92
[58]   Leukocyte migration and graft-versus-host disease [J].
Wysocki, CA ;
Panoskaltsis-Mortari, A ;
Blazar, BR ;
Serody, JS .
BLOOD, 2005, 105 (11) :4191-4199
[59]  
XUN CQ, 1994, BLOOD, V83, P2360